Monica Price was diagnosed with Crohn's just before Christmas, 2005, at the age of 50. She suffered from bloating and severe abdominal pain, and then developed welts on her shins (called erythema ...

New once-a-month jab can eliminate distressing symptoms for patients with severe bowel diseases like Crohn’s and ulcerative colitis in only three months By ETHAN ENNALS, HEALTH EDITOR ...

The Company’s award-winning research showcased a physiologically relevant system built from primary human cells derived from both healthy donors and patients with Ulcerative Colitis or Crohn’s ...

AbbVie's (ABBV) Skyrizi met both primary endpoints of non-inferiority for clinical remission at week 24 and superiority of endoscopic remission at week 48 versus J&J's Stelara in a head-to-head study.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved guselkumab (Tremfya) for the treatment of Crohn’s disease and ulcerative colitis (UC). Already used for plaque psoriasis and ...

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending mirikizumab (Omvoh) for adults with moderately to severely active Crohn’s disease who have not ...

In Crohn's disease, the immune system mistakenly attacks the intestines, causing diarrhea, pain, bleeding and infections. But after drinking worm eggs, markers of inflammation in Smith's blood ...

METHODOLOGY: Researchers retrospectively included 223 patients (median age, 38 years; 49.8% men) with active luminal Crohn's disease who did not respond to conventional treatment to assess the ...